Showing results (31-40 of 68) with videos related to
Sort By:
Pageof 7
Frontiers in Immunology|November 8, 2021
Early Initiation of Tocilizumab Treatment Against Moderate-to-Severe Myelitis in Neuromyelitis Optica Spectrum DisorderChen Du, Pei Zeng, Jin-Rui Han, et al.Multiple Sclerosis and Related Disorders|February 9, 2025
Effectiveness and safety of glucocorticoids bridging rituximab in neuromyelitis spectrum disorderChunyang Wang, Jia Liu, Xue Gao, et al.Multiple Sclerosis and Related Disorders|June 12, 2021
The occurrence of myelin oligodendrocyte glycoprotein antibodies in aquaporin-4-antibody seronegative Neuromyelitis Optica Spectrum Disorder: A systematic review and meta-analysisXindi Li, Chengyi Zhang, Dongmei Jia, et al.Chemico-Biological Interactions|February 23, 2026
Effects of Prenatal Exposure to Hexafluoropropylene Oxide Dimer Acid on Rat and Offspring Mammary Gland Development and Associated Hormone LevelsLu Liu, Wendong Liu, Libing Wang, et al.Journal of Neuroimmunology|March 4, 2021
Low-dose rituximab treatment for new-onset generalized myasthenia gravisHuining Li, Zhenning Huang, Dongmei Jia, et al.Molecular Plant Pathology|December 1, 2024
SsPtc3 Modulating SsSmk1-MAPK and Autophagy to Facilitate Growth and Pathogenicity in Sclerotinia sclerotiorumWenli Jiao, Dongmeng Ma, Qi Zuo, et al.Journal of Neuroinflammation|December 17, 2017
Infiltration and persistence of lymphocytes during late-stage cerebral ischemia in middle cerebral artery occlusion and photothrombotic stroke modelsYan Feng, Shiwei Liao, Changjuan Wei, et al.Molecular Cancer Research : MCR|February 1, 2008
Enhanced susceptibility to chemical induction of ovarian tumors in mice with a germ line p53 mutationYian Wang, Zhongqiu Zhang, Yan Lu, et al.Translational Cancer Research|February 4, 2022
KIT/PDGFRA/KDR amplification defines a novel molecular subtype of adenoid cystic carcinoma patients who may benefit from treatment with tyrosine kinase inhibitorsHelei Hou, Dongmei Jia, Weihua Yan, et al.Multiple Sclerosis and Related Disorders|November 29, 2025
A real-world comparative study on the efficacy and safety of tocilizumab and rituximab in patients with neuromyelitis optica spectrum disease and myelin oligodendrocyte glycoprotein antibody-associated diseaseYao Shi, Yulin Li, Xiaona Xu, et al.Pageof 7